Cell membrane proteomic analysis identifies proteins differentially expressed in osteotropic human breast cancer cells

Philippe Kischel, francois guillonneau, Bruno Dumont, Akeila BELLAHCENE, Verena Stresing, Philippe Clézardin, Edwin A De Pauw and Vincent Castronovo

Year 2008, Volume 10, Issue 9

Abstract

Metastatic breast cancer cells are characterized by their high propensity to colonize the skeleton and form bone metastases, causing major morbidity and mortality. Identifying key proteins involved in the osteotropic phenotype would represent a major step toward the development of both new prognostic markers and new effective therapies. Cell surface proteins differentially expressed in cancer cells are preferred potential targets for antibody-based targeted therapies. In this study, using cell surface biotinylation and a mass spectrometric approach, we have compared the profile of accessible cell surface proteins between the human breast cancer cell line MDA-MB-231 and its highly osteotropic B02 subclone. This strategy allowed the identification of several proteins either up- or down-regulated in the osteotropic cell line and differential protein expressions were validated using antibody-based techniques. Class I HLAs were downregulated in the bone metastatic variant, whereas αvβ3 integrins, among others, were consistently upregulated in this latter cell line. These results show that comprehensive profiling of the cell surface proteome of mother cancerous cell lines and derived organ-specific metastatic cell lines provides an effective approach for the identification of potential accessible marker proteins for both prognosis and antibody-based targeted therapies.

View Full Text PDF